**Core Concept**
Periglomerular fibrosis refers to the scarring of tissue surrounding the glomeruli, which are the filtering units of the kidney. This pathological change is often associated with chronic kidney diseases, particularly those involving the accumulation of excess fibrotic tissue.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of diabetic nephropathy, where prolonged hyperglycemia leads to the activation of various signaling pathways, resulting in the deposition of extracellular matrix proteins. This process is mediated by the transformation of mesangial cells into myofibroblasts, which produce excessive collagen and fibronectin, causing periglomerular fibrosis. The accumulation of fibrotic tissue impairs the glomerular filtration barrier, leading to the characteristic microalbuminuria and progressive kidney dysfunction seen in diabetic nephropathy.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because periglomerular fibrosis is not a hallmark of glomerulonephritis, although some forms of glomerulonephritis may exhibit similar glomerular scarring.
**Option B:** This option is incorrect because focal segmental glomerulosclerosis (FSGS) primarily involves the scarring of glomeruli, rather than the periglomerular tissue.
**Option C:** This option is incorrect because hypertensive nephrosclerosis typically results in more diffuse glomerular and vascular changes, rather than periglomerular fibrosis.

**Clinical Pearl / High-Yield Fact**
Diabetic nephropathy is often preceded by a prolonged period of hyperglycemia-induced glomerular hyperfiltration, which can be mitigated by tight blood glucose control. Early detection and management of diabetes mellitus are crucial in preventing the development of periglomerular fibrosis and subsequent kidney dysfunction.

**Correct Answer:** C. Diabetic nephropathy.